Short-Term Effects of Growth Hormone on Lipolysis, Glucose and Amino Acid Metabolism Assessed in Serum and Microdialysate of Healthy Young Men.


Journal

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 8 11 2019
medline: 9 9 2021
entrez: 8 11 2019
Statut: ppublish

Résumé

We investigated direct effects of a therapeutic growth hormone dose on lipolysis, glucose and amino acid metabolism. This crossover microdialysis trial involved six healthy male volunteers receiving single subcutaneous injections of both growth hormone (0.035 mg/kg) and placebo (0.9% sodium chloride). The investigation comprised three test days with standard diet. The first day served for adaptation, the second and third one for determining study data during 9 night hours with or without growth hormone. Abdominal subcutaneous microdialysate and blood were continuously collected and forwarded to a separate room next door where hourly taken samples were centrifuged and frozen until analysed. Growth hormone achieved the peak serum level after 3 h followed by a plateau-like course for the next 6 h. Glycerol in microdialysate started to rise 2 h following growth hormone injection achieving significance compared to placebo after 9 h ( As the result of a high single subcutaneous dose of GH, persistent lipolysis can be shown in continuously collected microdialysate and blood, but no indication for gluconeogenesis or protein anabolism.

Identifiants

pubmed: 31698478
doi: 10.1055/a-1027-6620
doi:

Substances chimiques

Amino Acids 0
Blood Glucose 0
Growth Hormone 9002-72-6
Glucose IY9XDZ35W2
Glycerol PDC6A3C0OX

Types de publication

Controlled Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-826

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Andreas Krebs (A)

Department of Pediatrics and Adolescence Medicine, Faculty of Medicine, University of Freiburg, Germany.

Andreas Baum (A)

Department of Pediatrics and Adolescence Medicine, Faculty of Medicine, University of Freiburg, Germany.

Jürgen Doerfer (J)

Department of Pediatrics and Adolescence Medicine, Faculty of Medicine, University of Freiburg, Germany.

Klaus Gempel (K)

Department of Clinical Chemistry, München Klinik Schwabing, München, Germany.

Michael Wurm (M)

Department of Pediatrics and Adolescence Medicine, Faculty of Medicine, University of Freiburg, Germany.

Corinna Brichta (C)

Department of Pediatrics and Adolescence Medicine, Faculty of Medicine, University of Freiburg, Germany.

Jörn Oliver Sass (JO)

Department of Pediatrics and Adolescence Medicine, Faculty of Medicine, University of Freiburg, Germany.

Karl Winkler (K)

Department of Clinical Chemistry, Faculty of Medicine, University of Freiburg, Germany.

Karl Otfried Schwab (KO)

Department of Pediatrics and Adolescence Medicine, Faculty of Medicine, University of Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH